Jacobs Levy Equity Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $849K | Sell |
181,877
-73,683
| -29% | -$344K | ﹤0.01% | 785 |
|
|
2025
Q1 | $1.4M | Buy |
+255,560
| New | +$1.4M | 0.01% | 742 |
|
|
2021
Q2 | – | Sell |
-162,321
| Closed | -$732K | – | 1129 |
|
|
2021
Q1 | $732K | Buy |
162,321
+25,924
| +19% | +$117K | 0.01% | 799 |
|
|
2020
Q4 | $671K | Buy |
136,397
+100,946
| +285% | +$497K | 0.01% | 811 |
|
|
2020
Q3 | $210K | Sell |
35,451
-17,992
| -34% | -$107K | ﹤0.01% | 957 |
|
|
2020
Q2 | $142K | Sell |
53,443
-23,317
| -30% | -$62K | ﹤0.01% | 989 |
|
|
2020
Q1 | $150K | Buy |
+76,760
| New | +$150K | ﹤0.01% | 923 |
|